Elite Pharmaceuticals, Inc. Accrued Income Taxes, Current
Elite Pharmaceuticals, Inc. (ELTP) had Accrued Income Taxes, Current of $1.06 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Income Taxes, Current $1.06M.
- 2026-03-31: Accrued Income Taxes, Current $594.18K.
- 2025-12-31: Accrued Income Taxes, Current $802.26K.
- 2025-09-30: Accrued Income Taxes, Current $268.31K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $1.06M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $594.18K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $802.26K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $268.31K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $753.41K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $340.61K 10-K · filed 2026-06-29 |
| 2024-12-31 | $505.91K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $420.86K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $699.10K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $485.33K 10-K · filed 2025-06-30 |
| 2023-06-30 | $564.99K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $414.99K 10-K · filed 2024-07-01 |
| 2022-12-31 | $54.55K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $50.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $414.99K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $414.99K 10-K · filed 2023-06-29 |